David Einhorn - Greenlight Capital
Holding/activity history for NeuBase Therapeutics Inc. (NBSE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 136,350 | 0.00 | $0.74 | ||
| 2023 Q3 | 136,350 | 0.01 | $0.87 | ||
| 2023 Q2 | 136,350 | 0.01 | Reduce 0.00% | 0.00 | $1.87 |
| 2023 Q1 | 136,351 | 0.03 | $3.70 | ||
| 2022 Q4 | 136,351 | 0.04 | $3.81 | ||
| 2022 Q3 | 136,351 | 0.08 | $7.90 | ||
| 2022 Q2 | 136,351 | 0.22 | $21.00 | ||
| 2022 Q1 | 136,351 | 0.33 | $37.60 | ||
| 2021 Q4 | 136,351 | 0.47 | $56.20 | ||
| 2021 Q3 | 136,351 | 0.66 | $72.20 | ||
| 2021 Q2 | 136,351 | 0.82 | Add 34.53% | 0.21 | $95.80 |
| 2021 Q1 | 101,351 | 1.04 | $147.80 | ||
| 2020 Q4 | 101,351 | 0.86 | $139.80 | ||
| 2020 Q3 | 101,351 | 1.27 | Add 6.50% | 0.08 | $151.81 |
| 2020 Q2 | 95,161 | 1.83 | Add 23.71% | 0.35 | $175.61 |
| 2020 Q1 | 76,923 | 1.57 | $142.40 | ||
| 2019 Q4 | 76,923 | 0.82 | $144.00 | ||
| 2019 Q3 | 76,923 | 0.55 | Buy | 0.55 | $99.80 |